Vertex Pharmaceuticals Inc

مادة اعلانية

Latest Update: 16 Nov 2024 00:59 Abu Dhabi Time.

Market Status: Closed

VRTX

Vertex Pharmaceuticals Inc

465.69

USD

-18.270

-3.78%

Open

478.56

Prev Close

465.70

PX_VOLUME

MARKET CAP (M)

121,607.66

DAY RANGE

458.10 - 479.94

52 WEEKS

342.64 - 519.88

Stock Statistics

Yearly Change

35.77%

Listed Shares (Million)

257.74

Earnings Multiple

32.15

Average 30-day trading volume

1,214,675.05

Price-to-book ratio

7.68

Earnings Per Share

14.05

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Revenue		2,771.90	2,645.60	2,690.60	2,517.70	2,483.50	2,493.20	2,374.80
Gross Profit		2,379.30	2,273.70	2,348.00	2,149.70	2,164.80	2,184.60	2,107.90
Operating Income		1,131.60	934.90	1,216.20	956.00	1,091.00	1,136.30	1,124.20
Net Income		1,045.40	-3,593.60	1,099.60	968.80	1,035.30	915.70	699.80
Profit Margin		37.71	-135.83	40.87	38.48	41.69	36.73	29.47

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		9,869.20	8,930.70	7,574.40	6,205.68
Gross Profit		8,607.00	7,850.40	6,670.20	5,469.38
Operating Income		4,307.50	4,378.40	2,779.00	2,869.39
Net Income		3,619.60	3,322.00	2,342.10	2,711.65
Profit Margin		36.68	37.20	30.92	43.70

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Total Assets		22,240.20	20,132.10	23,917.40	22,730.20	21,726.20	20,349.20	18,974.20
Total Liabilities		6,609.30	5,357.40	5,370.80	5,149.80	5,213.40	4,879.00	4,541.90
Total Equity		15,630.90	14,774.70	18,546.60	17,580.40	16,512.80	15,470.20	14,432.30

Cash Flows Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Cash From Operating Activities		1,369.80	-3,753.60	1,306.60	234.60	1,268.40	1,134.40	899.90
Cash From Investing Activities		-348.00	-463.70	-2,136.40	-886.50	-117.70	-303.90	-1,833.60
Cash From Financing Activities		-387.50	-358.60	-357.50	-119.80	-165.00	17.30	-294.70
Net Change in Cash		657.10	-4,578.40	-1,202.90	-744.30	963.20	857.80	-1,216.40

	Period Ending:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		3,537.30	4,129.90	2,643.50	3,253.50
Cash From Investing Activities		-3,141.70	-321.10	-340.90	99.39
Cash From Financing Activities		-562.20	-67.70	-1,478.00	-505.28
Net Change in Cash		-139.70	3,711.90	811.20	2,868.16

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

VRTX

Vertex Pharmaceuticals Inc